COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

• Main Authors: Ho, Wei Shen, Zhang, Ruirui, Tan, Yeong Lan, Chai, Christina Li Lin
• Other Authors: PHARMACY
• Format: Review
• Language: English
• Published: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Pharmacology & Pharmacy; Antivirals; COVID-19; Small molecule therapeutics; Drug discovery; Chloroquine (PubChem CID; 2719); Ivermectin (PubChem CID; 6321424); Lopinavir (PubChem CID; 92727); Ritonavir (PubChem CID; 392622); Remdesivir (PubChem CID; 121304016); Dexamethasone (PubChem CID; 5743); Baricitinib (PubChem CID; 44205240); Molnupiravir (Pubchem CID; 145996610); Nirmatrelvir (PubChem CID; 155903259); Chemical compounds studied in this article; Hydroxychloroquine (PubChem CID; 3652); ACUTE RESPIRATORY SYNDROME; IN-VITRO; LOPINAVIR-RITONAVIR; EBOLA-VIRUS; IVERMECTIN; INHIBITORS; CHLOROQUINE; EFFICACY; REMDESIVIR; DRUG
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/226977
• Institution: National University of Singapore

10.1016/j.phrs.2022.106201